GlassScriptPhysician profile
Samuel W Linford
NPI 1306091046
$7,634.66
in general payments reported to CMS, 2019-2025
16 companies · $331 in 2025
The $331 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $204 · 2020: $13.52 · 2021: $106 · 2022: $3,839 · 2023: $117 · 2024: $3,023 · 2025: $331.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,892 · Food and Beverage: $1,440 · Education: $139.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,892.14 |
| Food and Beverage | $1,440.42 |
| Education | $139.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $3,356.34 | 2019-2025 | Persona, Comprehensive Shoulder System, Comprehensive |
| Active Medical, LLC | $2,172.20 | 2022 | |
| Arthrex, INC. | $1,496.43 | 2022-2025 | |
| Heron Therapeutics, INC. | $169.76 | 2023-2024 | Zynrelef |
| Stryker Corporation | $131.21 | 2022-2025 | Mako, X3, Accolade |
| Anika Therapeutics, INC. | $85.00 | 2025 | Integrity Implant, Tactoset |
| Medacta USA, INC. | $36.56 | 2023 | Mecta |
| Ferring Pharmaceuticals INC. | $33.45 | 2023-2024 | Euflexxa |
| Solventum Corporation | $31.24 | 2025 | Prevena |
| Encore Medical, LP | $26.67 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $23.23 | 2025 | |
| Orthofix Medical, INC. | $16.84 | 2024-2025 | Spinal-Stim, Cervical-Stim, Physio-Stim |
| Bioventus LLC | $16.45 | 2024 | Durolane |
| Smith+Nephew, INC. | $13.52 | 2020 | |
| Pfizer INC. | $13.45 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Welch Allyn | $12.31 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Linford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.